Moolec Science SA MLECW
0.01 USD 0.00 (-1.43%)
At closeNov 2, 2026, 6:51 PM EST
0.00 0.00 -71.01%
After hours · Nov 2, 6:51 PM ET
0.0066 Day range 0.007
0.0066 52-week range 0.007
- YTD
- 0.00%
- 1 year
- 0.00%
Financial health
Altman Z-Score
-1.34 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
D+1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -0.4×
FY 2020 5y median -58.4× FY 2024
P/S 0.1×
FY 2020 5y median 0.1× FY 2024
P/B -0.6×
FY 2020 5y median 62.7× FY 2024
P/FCF -1.4×
FY 2020 5y median -165× FY 2024
EV/EBITDA -4.2×
FY 2020 5y median -24.5× FY 2024
EV/Sales 0.9×
FY 2020 5y median 0.9× FY 2024
FCF Yield -73.9%
FY 2020 5y median -0.6% FY 2024
Profitability
Gross Margin 34.2%
FY 2020 5y median 0.0% FY 2024
Operating Margin -3.1%
FY 2020 5y median -3.1% FY 2024
Net Margin -33.4%
FY 2020 5y median -33.4% FY 2024
ROE 169.0%
FY 2020 5y median -107.3% FY 2024
ROIC -5.3%
FY 2020 5y median -26.9% FY 2024
ROA -54.4%
FY 2020 5y median -54.4% FY 2024
Growth (YoY)
Revenue 5830.7%
FY 2020 FY 2024
Operating Income -15.9%
FY 2020 FY 2024
EPS (diluted) -8978.9%
FY 2020 FY 2024
Free Cash Flow -217.3%
FY 2020 FY 2024
Financial Health
Current Ratio 0.1×
FY 2020 5y median 0.4× FY 2024
Quick Ratio 0.1×
FY 2020 5y median 0.4× FY 2024
Debt / Equity -3.7×
FY 2020 5y median 0.1× FY 2024
Net Debt / EBITDA -3.6×
FY 2020 5y median 0.3× FY 2024
Interest Coverage -0.3×
FY 2020 5y median -7.8× FY 2024
Dividends
Dividend Yield 0.0%
FY 2020 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2020 5y median 0.0% FY 2024
Annual · latest fiscal year ends 2025-06-30